tanios bekaii-saab, md: reinitiating regorafenib in patients with mcrc
Published 8 years ago • 56 plays • Length 0:28
Download video MP4
Download video MP3
Similar videos
-
1:20
tanios bekaii-saab, md: clinical data supporting regorafenib in mcrc
-
1:12
tanios bekaii-saab, md: mechanisms of action in regorafenib
-
1:20
dr. bekaii-saab on the use of regorafenib in patients with mcrc
-
1:45
tanios bekaii-saab, md: main adverse events with regorafenib
-
4:49
botensilimab plus balstilimab for metastatic heavily pretreated mss colorectal cancer
-
1:40:18
colorectal cancer
-
1:28:39
immune 36: aberrant immunity in covid-19
-
0:58
tara seery, md: reinitiating regorafenib in patients with mcrc
-
1:16
dr. bekaii-saab on tas-102 and regorafenib in mcrc
-
1:21
tanios bekaii-saab, md: regorafenib dose adjustments
-
2:19
tanios bekali-saab, md, on utilizing regorafenib (stivarga) and trifluridine (lonserf)
-
0:20
copy of dr. bekaii-saab on tas-102 and regorafenib in mcrc
-
1:27
tanios bekaii-saab, md, comments on dosing regorafenib (stivarga) in 3rd line treatment of mcrc
-
8:18
the optimal dosing strategy for regorafenib in mcrc
-
1:39
dr. bekaii-saab on dosing strategies with regorafenib in crc
-
2:17
tanios bekaii-saab, md: first-line treatments in unresectable colon cancer
-
0:57
dr. bekaii-saab discusses the next steps with regorafenib in crc
-
0:26
tanios bekaii-saab, md: ras mutations in metastatic colorectal cancer
-
1:21
dr. bekaii-saab discusses regorafenib use in mcrc
-
4:32
tanios bekaii-saab, md: cost issues with ct regimens and bevacizumab
-
1:22
tanios bekaii-saab, md: experience with patients on bevacizumab plus chemotherapy
-
1:27
tanios bekaii-saab, md: mutations in colorectal cancer
Clip.africa.com - Privacy-policy